Striving for a better quality of life for all.

Healthcare at a glance

At FII Institute, we are disrupting the traditional healthcare and life-sciences industry through new applications of technology and research with the objective of improving healthcare access – especially in uninsured markets – as well as quality and efficiency.

We address the spread and prevalence of communicable and non-communicable diseases.

ESG Check

Our focus looks at managing health risks in the post-Covid “new normal”.

Featured Publications

Cancer Vaccine Fairness: Tumor No More

This report examines the potential impact and challenges of cancer vaccines, proposing a debate about the best and most equitable way to put an end to cancer. It includes illustrations by Daniel Hertzberg, and discusses the need for studies with clearly defined plans to treat a defined number of patients, as well as the potential of mobile production facilities for mRNA.

1 2 3 13

Latest Publications on Healthcare

Cancer Vaccine Fairness: Tumor No More

This report examines the potential impact and challenges of cancer vaccines, proposing a debate about the best and most equitable way to put an end to cancer. It includes illustrations by Daniel Hertzberg, and discusses the need for studies with clearly defined plans to treat a defined number of patients, as well as the potential of mobile production facilities for mRNA.

Spotlight Series: Toilets for the Future

Discover the future of sanitation and its impact on global health in our comprehensive Spotlight Series Report, “Toilets for the Future.” This enlightening resource delves deep into the past, present, and promising future of sanitation systems worldwide, emphasizing reducing the global threat of infectious diseases. The report explores critical topics such as: The dire current […]

Spotlight Series: Disease Data

IN SEPTEMBER 2021, THE FII INSTITUTE launched its Global Infectious Disease Index (GIDI), providing valuable information to help health professionals and the general public assess the readiness and vulnerability of global healthcare systems in tackling endemic and emerging epidemic diseases. Since its launch, GIDI has acquired a reputation as a scientifically rigorous and credible resource, unique in its field, that serves as a transparent metric and a unified source of truth for anyone with an interest in infectious diseases.

Two-pager: The Cigarette of Tomorrow

Cyber-Addiction and Cyber-Bullying pose serious risks for the health and wellbeing of the individual – especially for children and adolescents. How can society reduce these risks and increase digital wellbeing?

One-pager: Vaccine Apartheid

The Covid-19 pandemics offered a great opportunity for the Global community to practice international solidarity. But the opportunity was missed, the multi-national institutions have failed to ensure equitable vaccine access. The prevailing “My-interest-first” policies have reduced the overall efficacy of the vaccination campaign and damaged the trust in global solidarity. International health policy needs a shift to humanity.

Spotlight Series: PRO ANTIBODIES

Pneumonia is, in most cases, a curable or preventable disease. But it remains the leading infectious cause of death globally among children under the age of five, disproportionately affecting the most deprived and marginalized. An effective and affordable vaccine is the best way to tackle this global challenge.

Ominous Omicron

Just as the world began glimpsing the light at the end of the tunnel of an arduous battle against the COVID-19 pandemic - bolstered by the development of several highly efficient vaccines - a new variant of “high concern” as designated by WHO has emerged. And, while the debate continues to rage about the origins of SARS-CoV-2 and how much of it, if any, was human influenced, there should be no doubt that humans shoulder the lion’s share of the blame for the emergence of the Omicron variant.

KSA: Partnering to advance health security

As previously witnessed with the major outbreaks of West Africa Ebola virus in 2014, Middle East Respiratory Syndrome (MERS) in 2012, and Zika in 2016, emerging infectious diseases (EIDs) have too often been neglected or perceived as distant problems. Despite repeated warnings of the increasing threat of epidemics and pandemics, both public and private sector actors have repeatedly failed to prioritize the forward-looking investments, systems, and structures that are necessary to ensure that vaccines, therapeutics, diagnostics, and other medical countermeasures and lifesaving tools are ready to deploy right at the outset of an outbreak to curb the spread of disease before it becomes a global health emergency.

EMERGING DISEASES AND CLIMATE CHANGE

Climate change is a growing factor in the emergence of infectious disease. We need decisive action now to limit global warming, more investment in research to improve our understanding, and “One Health” policies that consider together the well-being of people, animals and ecosystems.

Executive Briefing: Preventing the Next Global Pandemic

Tuberculosis (TB) is among the world’s most lethal diseases, killing 1.4 million people each year, equivalent to more than 80% of the victims of COVID-19 in 20201 .The majority (66%) of new cases come from 8 developing countries2, but the threat of a global pandemic is real as cases of drug-resistant TB rise3 with a 10% increase between 2018 and 20194. As we emerge from the ravages of the COVID-19 pandemic, we must learn from our mistakes and act now to develop an effective TB vaccine before TB brings tomorrow's global health catastrophe.

Spotlight Series – Fortifying Medical Supply Chains

Substandard and falsified medicines are a major threat to public health and responsible for hundreds of thousands of deaths each year – mostly in low- and middle-income countries. Digital, AI-based control systems throughout the supply chain and at end-user level can help to curb the activities of the global counterfeit crime networks.

Winning the battle against disease together

A report series as we face one of the greatest global challenges in recent history. Covid-19 is unprecedented in its scale, impact, and speed. At the same time, we may have a unique opportunity to shift our thinking on key health concerns, drive an exceptional level of global collaboration, and support the development of ground-breaking technologies.

Healthcare Equity – A Moral Imperative

The “Healthcare Impact report 2020” published by the FII Institute emphasizes health equity as a moral imperative. There’s a stark global health inequity exhibited by the vast difference in life expectancy depending on where one is born. Additionally, a double burden arises when healthcare costs exceed a certain percentage of household income, forcing difficult decisions […]

chevron-down